关注
Manuel Gorostidi
Manuel Gorostidi
Department of Nephrology, Hospital Universitario Central de Asturias
在 sespa.es 的电子邮件经过验证
标题
引用次数
引用次数
年份
Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring
A de la Sierra, J Segura, JR Banegas, M Gorostidi, JJ de la Cruz, ...
Hypertension 57 (5), 898-902, 2011
11082011
Relationship between clinic and ambulatory blood-pressure measurements and mortality
JR Banegas, LM Ruilope, A de la Sierra, E Vinyoles, M Gorostidi, ...
New England Journal of Medicine 378 (16), 1509-1520, 2018
6352018
Documento de la Sociedad Española de Nefrología sobre las guías KDIGO para la evaluación y el tratamiento de la enfermedad renal crónica
M Gorostidi, R Santamaría, R Alcázar, G Fernández-Fresnedo, ...
Nefrología (Madrid) 34 (3), 302-316, 2014
526*2014
Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients
A De La Sierra, J Redon, JR Banegas, J Segura, G Parati, M Gorostidi, ...
Hypertension 53 (3), 466-472, 2009
4742009
High prevalence of masked uncontrolled hypertension in people with treated hypertension
JR Banegas, LM Ruilope, A de la Sierra, JJ de la Cruz, M Gorostidi, ...
European heart journal 35 (46), 3304-3312, 2014
2692014
Effectiveness of blood pressure control outside the medical setting
JR Banegas, J Segura, J Sobrino, F Rodríguez-Artalejo, A De La Sierra, ...
Hypertension 49 (1), 62-68, 2007
2582007
Prevalencia de enfermedad renal crónica en España: impacto de la acumulación de factores de riesgo cardiovascular
M Gorostidi, M Sánchez-Martínez, LM Ruilope, A Graciani, JJ de la Cruz, ...
Nefrología 38 (6), 606-615, 2018
2492018
Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide
RE Schmieder, T Philipp, J Guerediaga, M Gorostidi, B Smith, ...
Circulation 119 (3), 417-425, 2009
1932009
Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs
A de la Sierra, JR Banegas, A Oliveras, M Gorostidi, J Segura, ...
Journal of hypertension 30 (6), 1211-1216, 2012
1862012
Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20 000-patient database in Spain
M Gorostidi, J Sobrino, J Segura, C Sierra, Á De La Sierra, RH Del Rey, ...
Journal of hypertension 25 (5), 977-984, 2007
1822007
Evaluación y tratamiento de la hipertensión arterial en España. Documento de consenso
A De La Sierra, M Gorostidi, R Marín, J Redón, JR Banegas, P Armario, ...
Medicina clínica 131 (3), 104-116, 2008
1812008
Documento de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre las guías ACC/AHA 2017 de hipertensión arterial
T Gijón-Conde, M Gorostidi, M Camafort, M Abad-Cardiel, ...
Hipertensión y riesgo vascular 35 (3), 119-129, 2018
1752018
Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event study
A de la Sierra, JR Banegas, J Segura, M Gorostidi, LM Ruilope, ...
Journal of hypertension 30 (4), 713-719, 2012
1732012
Long-term prognosis of hypertension in pregnancy
R Marín, M Gorostidi, CG Portal, M Sánchez, E Sánchez, J Alvarez
Hypertension in pregnancy 19 (2), 199-209, 2000
1632000
Nocturnal hypertension or nondipping: which is better associated with the cardiovascular risk profile?
A de la Sierra, M Gorostidi, JR Banegas, J Segura, JJ de la Cruz, ...
American journal of hypertension 27 (5), 680-687, 2014
1542014
Prevalence of white-coat and masked hypertension in national and international registries
M Gorostidi, E Vinyoles, JR Banegas, A de la Sierra
Hypertension Research 38 (1), 1-7, 2015
1512015
Ethnic differences in the degree of morning blood pressure surge and in its determinants between Japanese and European hypertensive subjects: data from the ARTEMIS study
S Hoshide, K Kario, A de la Sierra, G Bilo, G Schillaci, JR Banegas, ...
Hypertension 66 (4), 750-756, 2015
1202015
Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: a 5,693-patient cross-sectional analysis from Spain
M Gorostidi, PA Sarafidis, A de la Sierra, J Segura, JJ de la Cruz, ...
American journal of kidney diseases 62 (2), 285-294, 2013
1092013
Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis
R Marín, M Gorostidi, F Fernández-Vega, R Álvarez-Navascués
Kidney international 68, S52-S56, 2005
1082005
Guía sobre el diagnóstico y tratamiento de la hipertensión arterial en España 2005
R Marín, Á de la Sierra, P Armario, C Campo, JR Banegas, M Gorostidi
Medicina clínica 125 (1), 24-34, 2005
992005
系统目前无法执行此操作,请稍后再试。
文章 1–20